Related Experiment Video

Updated: May 17, 2026

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
08:50

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat

Published on: July 3, 2013

[Contrast nephropathy and prevention]

V Teplan1

  • 1Klinika nefrologie Transplantcentra IKEM Praha. vladimir.teplan@ikem.cz

Vnitrni Lekarstvi
|October 17, 2012
PubMed

Insights

Contrast-induced nephropathy (CIN) prevention strategies include hydration and N-acetylcysteine. Trimetazidine (TMZ) shows promise as a cytoprotective agent for CIN prophylaxis in high-risk patients.

Area of Science:

  • Nephrology
  • Cardiology
  • Pharmacology

Context:

  • Contrast-induced nephropathy (CIN) is a significant risk following radiocontrast procedures, particularly in patients with pre-existing renal impairment.
  • Identifying effective preventative measures is crucial for managing high-risk patient populations.

Purpose:

  • To explore the potential of trimetazidine (TMZ), a cytoprotective anti-ischemic agent, as a prophylactic treatment against contrast-induced nephropathy (CIN).
  • To review current recommendations for CIN prevention, including hydration, bicarbonate, and N-acetylcysteine, and discuss adjunctive therapies.

Summary:

  • Trimetazidine (TMZ) exhibits antioxidant and metabolic properties, influencing cellular and mitochondrial reperfusion, positioning it as a candidate for CIN prophylaxis.
  • Standard preventive measures involve optimizing intravenous hydration, potentially with bicarbonate and N-acetylcysteine.
  • In severe instances, hemofiltration may aid in contrast agent elimination, while urinary NGAL offers early detection of tubular damage.

Impact:

  • This research highlights trimetazidine as a potential therapeutic agent to mitigate CIN risk.
  • It emphasizes the importance of a multi-faceted approach to CIN prevention, combining established methods with novel pharmacological interventions.
  • Early diagnostic markers like urinary NGAL could improve patient outcomes.

More Related Videos

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin07:38

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin

Published on: May 6, 2018

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...